17-58206036-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001321269.2(MKS1):c.1640G>A(p.Gly547Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,578,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 5/5 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
NM_001321269.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000316 AC: 48AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000778 AC: 15AN: 192760Hom.: 0 AF XY: 0.0000480 AC XY: 5AN XY: 104128
GnomAD4 exome AF: 0.0000288 AC: 41AN: 1425942Hom.: 0 Cov.: 32 AF XY: 0.0000212 AC XY: 15AN XY: 706444
GnomAD4 genome AF: 0.000316 AC: 48AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.000283 AC XY: 21AN XY: 74296
ClinVar
Submissions by phenotype
MKS1-related disorder Uncertain:1
The MKS1 c.1640G>A variant is predicted to result in the amino acid substitution p.Gly547Glu. This variant corresponds to a post-coding position in the primary transcript of this gene (NM_017777.3:c.*43G>A). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.14% of alleles in individuals of African descent in gnomAD, which may be too common to be a primary cause of disease. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at